Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | 最新消息 - 中國醫藥大學附設醫院

:::

院外單位健康通報

實名登記系統

"> 回首頁LOGO按鈕

繁簡 EN

最新消息

News & Message

:::

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

最新消息

2026/2/3

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

回上頁

相關文章

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

$INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer$

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

側邊開關圖示

中國醫點通

百度搜狗 360搜索上海市区出现首台无人驾驶清扫机器人，工作起来“情绪稳定” 晚晚老公正在被市场淘汰的6种电器，年轻人看不上，老一辈无法理解我国首个血友病B基因治疗药物获批上市，来自上海的它为何值得期待？创业板指涨超1%

<code id='f1917'></code><style id='6f1e7'></style>

<acronym id='66734'></acronym>

<center id='c4466'><center id='12046'><tfoot id='035ee'></tfoot></center><abbr id='8a7a7'><dir id='6c5b8'><tfoot id='9a038'></tfoot><noframes id='3efe7'>

<optgroup id='0fa7f'><strike id='ab0da'><sup id='79ebb'></sup></strike><code id='b6ba9'></code></optgroup>

<b id='54395'><label id='86583'><select id='3f2eb'><dt id='5439f'><span id='a0e4b'></span></dt></select></label></b><u id='a8e9a'></u>

~~<i id='b585e'><strike id='538ab'><tt id='25490'><pre id='c7ec5'></pre></tt></strike></i>~~